MYH Gene Analysis for Multiple Adenoma, Y165C and G382D
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Determining whether the clinical phenotype of multiple colorectal adenomas is due to biallelic MYH mutations in the affected individual
Predictive testing and familial risk assessment by carrier screening for multiple colorectal adenomatous polyps when an MYH mutation has been identified in an affected family member
Genetics Test Information Provides information that may help with selection of the correct test or proper submission of the test request
Tests for the Y176C and G382D mutations only.
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
See Colonic Adenomatous Polyposis Syndromes Testing Algorithm in Special Instructions.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Polymerase Chain Reaction (PCR)
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
MYH Gene Analysis